I48.0
Conditions
Interventions
Group 1: Patients with at least moderate AV valve regurgitation undergoing a rhythm control strategy (electrical cardioversion or catheter ablation) for persistent atrial fibrillation. As part of the
Sponsors
Universitätsherzzentrum Freiburg-Bad Krozingen
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 2. Written informed consent for study participation prior to enrollment (only applicable for prospective study part) 3. Ability to understand the nature of the trial and the trial related procedures and to comply with them (only applicable for prospective study part) 4. = moderate MR or TR Additional criterion for the rhythm control group: 1. A diagnosis of persistent AFib or atypical atrial flutter and an applied rhythm control (EC/CA) during baseline visit
Exclusion criteria
Exclusion criteria: 1. Prior cardiac surgery, left atrial catheter ablation 2. Patients with primary MR/TR 3. Patients with secondary MR/TR due to endocarditis 4. Short life expectancy due to comorbid conditions 5. Severe aortic valvulopathy (= Grade 3) 6. Acute inflammatory or infectious disease 7. Implant of CRT or CRT-D within the last 30 days 8. CIED related TR Additional Exclusion criterion for the rhythm control group (group 1) 1. Prior transcatheter edge-to-edge repair of MR/TR Additional Exclusion criterion for the TEER group (group 2) 1. Applied rhythm control (CA or EC) during baseline stay
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AV valve regurgitation severity | — |
Secondary
| Measure | Time frame |
|---|---|
| atrial dilation AF burden | — |
Countries
Germany
Contacts
Public ContactLena Koch
Universitätsherzzentrum Freiburg Bad Krozingen
Outcome results
None listed